covid vaccine fda news

Order byBest matchMost fresh

Covid-19, FDA and vaccines

Top News

Overview

Impacts

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine access, and medical ethics.

· 8h · on MSN

· 1d

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

· 1d · on MSN

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 16h

· 2d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

STAT · 10h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

· 1d

FDA panel says Covid vaccines can stay the same for fall amid access concerns

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula,

8hon MSN

FDA picks a new strain for fall Covid vaccines. Here's what it means for your next shot.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most at-risk Americans this fall.

1don MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.

FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

2don MSN

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

3don MSN

Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.